Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population.

Helene Gellert-Kristensen Tom G Richardson George Davey SmithBørge G NordestgaardAnne Tybjaerg-HansenStefan Stender

Published in: Hepatology (Baltimore, Md.) (2021)

A GRS for fatty liver disease confers up to a 12-fold higher risk of cirrhosis and up to a 29-fold higher risk of HCC in individuals from the general population.

Keyphrases

copy number